Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 1831 AL 1845

Mitochondrial homeostasis molecules: regulation by a trio of recessive Parkinson's disease genes

Han JY, Kim JS, Son JH.

Exp Neurobiol. 2014 Dec;23(4):345-51. doi: 10.5607/en.2014.23.4.345. Epub 2014 Dec 12.

What is the Clinical Significance of Cerebrospinal Fluid Biomarkers in Parkinson's disease? Is the Significance Diagnostic or Prognostic?

Kim D, Paik JH, Shin DW, Kim HS, Park CS, Kang JH.

Exp Neurobiol. 2014 Dec;23(4):352-64. doi: 10.5607/en.2014.23.4.352. Epub 2014 Dec 12.

Trunk muscle exercises as a means of improving postural stability in people with Parkinson's disease: a protocol for a randomised controlled trial

Hubble RP, Naughton GA, Silburn PA, Cole MH.

BMJ Open. 2014 Dec 31;4(12):e006095. doi: 10.1136/bmjopen-2014-006095.

The prevalence of Parkinson's disease continues to rise after 80 years of age: a cross-sectional study of Chinese veterans

Zou YM, Tan JP, Li N, Yang JS, Yu BC, Yu JM, Du W, Zhang WJ, Cui LQ, Wang QS, Xia XN, Li JJ, Zhou PY, Zhang BH, Liu ZY, Zhang SG, Sun LY, Liu N, Deng RX, Ma LH, Chen WJ, Zhang YQ, Liu J, Zhang SM, Lan XY, Zhao YM, Wang LN.

Eur Rev Med Pharmacol Sci. 2014;18(24):3908-15.

New drug treatments show neuroprotective effects in Alzheimer's and Parkinson's diseases

Hölscher C.

Neural Regen Res. 2014 Nov 1;9(21):1870-3. doi: 10.4103/1673-5374.145342.

[Effectiveness of music in brain rehabilitation. A systematic review]

Sihvonen AJ, Leo V, Särkämö T, Soinila S.

Duodecim. 2014;130(18):1852-60.

Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update

Brichta L, Greengard P.

Front Neuroanat. 2014 Dec 15;8:152. doi: 10.3389/fnana.2014.00152. eCollection 2014.

Parkinson's disease: animal models and dopaminergic cell vulnerability

Blesa J, Przedborski S.

Front Neuroanat. 2014 Dec 15;8:155. doi: 10.3389/fnana.2014.00155. eCollection 2014.

Alpha-synuclein spreading in Parkinson's disease

Recasens A, Dehay B.

Front Neuroanat. 2014 Dec 18;8:159. doi: 10.3389/fnana.2014.00159. eCollection 2014.

Akinetic crisis in Parkinson's disease is associated with a severe loss of striatal dopamine transporter function: a report of two cases

Kaasinen V, Joutsa J, Noponen T, Päivärinta M.

Case Rep Neurol. 2014 Nov 26;6(3):275-80. doi: 10.1159/000369448. eCollection 2014 Sep.

A neuroleptic malignant-like syndrome (NMLS) in a patient with Parkinson's disease resolved with rotigotine: a case report

Fiore S, Persichino L, Anticoli S, De Pandis MF.

Acta Biomed. 2014 Dec 17;85(3):281-4.

Genome-wide association studies in neurology

Tan MS, Jiang T, Tan L, Yu JT.

Ann Transl Med. 2014 Dec;2(12):124. doi: 10.3978/j.issn.2305-5839.2014.11.12.

Application of next-generation sequencing technologies in Neurology

Jiang T, Tan MS, Tan L, Yu JT.

Ann Transl Med. 2014 Dec;2(12):125. doi: 10.3978/j.issn.2305-5839.2014.11.11.

[Deep Brain Stimulation - an effective therapy not only for Parkinson's disease]

Kathmann W.

Dtsch Med Wochenschr. 2014 Nov;139(48):2434-5. doi: 10.1055/s-0034-1374726.

Muscle artifacts in single trial EEG data distinguish patients with Parkinson's disease from healthy individuals

Weyhenmeyer J, Hernandez ME, Lainscsek C, Sejnowski TJ, Poizner H.

Annu Int Conf IEEE Eng Med Biol Soc. 2014;2014:3292-5. doi: 10.1109/EMBC.2014.6944326.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias